Arrowhead Pharmaceuticals, Inc.

    Jurisdiction
    United States
    LEI
    549300O3CSB8T7OZ3D66
    ISIN
    US04280A1007 (ARWR)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    46 / 100
    Worse than peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    7 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7

    Profile

    Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Read full profile

    Fundamentals

    Net revenue
    €699.83M
    Gross margin
    35.4%
    EBIT
    -€92.09M
    EBIT margin
    -13.2%
    Net income
    -€128.79M
    Net margin
    -18.4%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €303.29M -56.7% -€356.32M +176.7%
    €294.19M -3.0% -€406.19M +14.0%
    €398.61M +35.5% -€253.71M -37.5%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Hamilton James C Chief Medical Officer -15K $25.00 -$375.00K
    Hamilton James C Chief Medical Officer -10K $20.00 -$200.00K

    Earnings Calls

    Add to watchlist

    Notifications